August 11, 2025

Which Generative AI Model is the Best Diagnostician?

Comparative evaluation highlights current limitations and potential of LMMs in chest CT diagnostics

The Pathologist

August 07, 2025

Metagenomics Reshapes Intensive Care Units

UK hospitals are using real-time sequencing to detect infections faster, improve patient outcomes, and support national surveillance

The Pathologist

July 29, 2025

Extended Outcomes With Addition of Sugemalimab to First-Line Chemotherapy in Metastatic NSCLC

In a 4-year follow-up of the Chinese phase III GEMSTONE-302 trial reported in The Lancet Oncology, Zhou et al examined the survival benefit of adding the PD-L1 inhibitor sugemalimab to first-line plat...

The ASCO Post

July 29, 2025

Update to ASCO Living Guideline for NSCLC Without Driver Alterations Includes First Comparison of Immunotherapy Options

ASCO has issued a new update to its living guideline regarding therapy for stage IV non–small cell lung cancer (NSCLC) without driver alterations, based on results of three studies published recently....

The ASCO Post

July 16, 2025

Roswell Park Adopts New Robotic Bronchoscopy System for More Accurate Biopsies

Roswell Park is utilizing a new tool, the Galaxy robotic bronchoscope system, for more accurate lung nodule imaging and biopsies.

Roswell Park Comprehensive Cancer Center

July 12, 2023

Changing How Immune Checkpoint Inhibitors Are Delivered Could Reduce Costs by 14%, Study Finds

Investigators have found that millions of dollars could be saved annually across the Veterans Health Administration by reconsidering how immune checkpoint inhibitors are delivered, according to a new ...

The ASCO Post

October 29, 2024

New Data Challenges Pediatric Sinusitis Treatment Guidelines

A JAMA review revealed that only 26% of pediatric ABRS patients treated with placebo required subsequent antibiotic therapy, prompting questions about current guidelines recommending first-line antibiotic use in children with sinusitis.

Conexiant

November 13, 2024

Is COPD Set to Affect 600M Globally?

GOLD 2025 highlights new pathways and advanced COPD therapies like ensifentrine and dupilumab to reduce exacerbations and address emerging COPD phenotypes.

Conexiant

May 07, 2025

Cystic Fibrosis: New Evidence-Based Guidelines for Newborn Screening

New Cystic Fibrosis Foundation guidelines aim to improve consistency, equity, and accuracy in CF newborn screening nationwide.

Conexiant